A detailed history of Formidable Asset Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Formidable Asset Management, LLC holds 1,459 shares of UTHR stock, worth $528,508. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,459
Previous 1,567 6.89%
Holding current value
$528,508
Previous $499,000 4.61%
% of portfolio
0.09%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$311.04 - $363.55 $33,592 - $39,263
-108 Reduced 6.89%
1,459 $522,000
Q2 2024

Aug 08, 2024

SELL
$228.26 - $319.04 $413,378 - $577,781
-1,811 Reduced 53.61%
1,567 $499,000
Q1 2024

May 15, 2024

SELL
$210.76 - $249.51 $36,250 - $42,915
-172 Reduced 4.85%
3,378 $775,000
Q4 2023

Feb 07, 2024

SELL
$214.88 - $256.94 $18,479 - $22,096
-86 Reduced 2.37%
3,550 $780,000
Q3 2023

Nov 09, 2023

BUY
$211.82 - $248.24 $11,226 - $13,156
53 Added 1.48%
3,636 $821,000
Q2 2023

Aug 15, 2023

BUY
$205.19 - $232.99 $72,637 - $82,478
354 Added 10.96%
3,583 $791,000
Q1 2023

May 09, 2023

BUY
$212.99 - $276.17 $297,973 - $386,361
1,399 Added 76.45%
3,229 $723,000
Q4 2022

Feb 07, 2023

SELL
$205.95 - $280.43 $102,975 - $140,215
-500 Reduced 21.46%
1,830 $509,000
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $10,368 - $12,452
51 Added 2.24%
2,330 $491,000
Q2 2022

Aug 16, 2022

BUY
$174.81 - $241.14 $24,298 - $33,518
139 Added 6.5%
2,279 $536,000
Q1 2022

May 04, 2022

SELL
$166.16 - $213.96 $7,144 - $9,200
-43 Reduced 1.97%
2,140 $384,000
Q4 2021

Feb 07, 2022

BUY
$184.32 - $216.08 $402,370 - $471,702
2,183 New
2,183 $472,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Formidable Asset Management, LLC Portfolio

Follow Formidable Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.